MENU
FENC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fennec Pharmaceuticals (FENC) Ownership - Who owns Fennec Pharmaceuticals?
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
68 TW Alexander Drive
Phone
+1 919 636-4530
Employees
29
Web
https://www.fennecpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
238.22M
P/E Ratio
60.43
Total Cash
40.32M
Projected Growth
N/A
Total Debt
32.1M
Revenue
49.35M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
1.46
Total Debt/Equity
N/A
Revenue/Share
1.13 USD as % of share price
Fundamentals
FENC
Capitalization
238M
P/E Ratio
60.43
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
40.3M
Total Cash/Share
1.46
Total Debt
32.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.13%
Revenue
49.3M
ROE
N/A
Book Value
-5.17M
P/B Ratio
52.91
Cash Flow
N/A
Earnings
-0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
145M
Current Ratio
7.80
Current Revenue Per Employee
240482.77
Dividends Per Share - Security
N/A
EBITDA
3.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.54
Revenue To Assets
-2.91
Shares Held By Institutions
119M
Shares Outstanding - Current
27.6M
Total Liabilities
64.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
28.481
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic products based on cell adhesion
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
68 TW Alexander Drive
Phone
+1 919 636-4530
Employees
29
Web
https://www.fennecpharma.com